135 related articles for article (PubMed ID: 21635205)
1. Treatment of refractory or relapsed acquired aplastic anemia: review of established and experimental approaches.
Füreder W; Valent P
Leuk Lymphoma; 2011 Aug; 52(8):1435-45. PubMed ID: 21635205
[TBL] [Abstract][Full Text] [Related]
2. Management of aplastic anemia after failure of frontline immunosuppression.
Pierri F; Dufour C
Expert Rev Hematol; 2019 Oct; 12(10):809-819. PubMed ID: 31311355
[No Abstract] [Full Text] [Related]
3. Management of the refractory aplastic anemia patient: what are the options?
Marsh JC; Kulasekararaj AG
Hematology Am Soc Hematol Educ Program; 2013; 2013():87-94. PubMed ID: 24319168
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in drug therapy for aplastic anemia.
Willis L; Rexwinkle A; Bryan J; Kadia TM
Ann Pharmacother; 2014 Nov; 48(11):1469-78. PubMed ID: 25184310
[TBL] [Abstract][Full Text] [Related]
5. Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia.
Scheinberg P; Nunez O; Weinstein B; Scheinberg P; Wu CO; Young NS
Blood; 2012 Jan; 119(2):345-54. PubMed ID: 22067384
[TBL] [Abstract][Full Text] [Related]
6. Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab).
Risitano AM; Schrezenmeier H
Bone Marrow Transplant; 2013 Feb; 48(2):186-90. PubMed ID: 23222381
[TBL] [Abstract][Full Text] [Related]
7. Eltrombopag for the treatment of aplastic anemia: current perspectives.
Lum SH; Grainger JD
Drug Des Devel Ther; 2016; 10():2833-2843. PubMed ID: 27695288
[TBL] [Abstract][Full Text] [Related]
8. [Aplastic anemia: Current state of diagnosis and treatment].
Schrezenmeier H; Körper S; Höchsmann B
Internist (Berl); 2015 Sep; 56(9):989-99. PubMed ID: 26216866
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive therapy for transplant-ineligible aplastic anemia patients.
Schrezenmeier H; Körper S; Höchsmann B
Expert Rev Hematol; 2015 Feb; 8(1):89-99. PubMed ID: 25572607
[TBL] [Abstract][Full Text] [Related]
10. Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.
Kook H; Chung NG; Kang HJ; Im HJ
Int J Hematol; 2016 Apr; 103(4):380-6. PubMed ID: 26894608
[TBL] [Abstract][Full Text] [Related]
11. Management of the refractory aplastic anemia patient: what are the options?
Marsh JC; Kulasekararaj AG
Blood; 2013 Nov; 122(22):3561-7. PubMed ID: 24052548
[TBL] [Abstract][Full Text] [Related]
12. Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
Rzepecki P; Sarosiek T; Szczylik C
Jpn J Clin Oncol; 2006 Jan; 36(1):46-9. PubMed ID: 16423840
[TBL] [Abstract][Full Text] [Related]
13. [Acquired aplastic anemia].
Yamazaki H
Rinsho Ketsueki; 2016 Feb; 57(2):91-7. PubMed ID: 26935624
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and Treatment of Aplastic Anemia.
Peslak SA; Olson T; Babushok DV
Curr Treat Options Oncol; 2017 Nov; 18(12):70. PubMed ID: 29143887
[TBL] [Abstract][Full Text] [Related]
15. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
Kennedy-Nasser AA; Leung KS; Mahajan A; Weiss HL; Arce JA; Gottschalk S; Carrum G; Khan SP; Heslop HE; Brenner MK; Bollard CM; Krance RA
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1277-84. PubMed ID: 17162209
[TBL] [Abstract][Full Text] [Related]
16. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in treatment of aplastic anemia.
Shin SH; Lee SE; Lee JW
Korean J Intern Med; 2014 Nov; 29(6):713-26. PubMed ID: 25378968
[TBL] [Abstract][Full Text] [Related]
18. The optimal immunosuppressive therapy for aplastic anemia.
Shin SH; Lee JW
Int J Hematol; 2013 May; 97(5):564-72. PubMed ID: 23605367
[TBL] [Abstract][Full Text] [Related]
19. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
20. The diagnosis and treatment of aplastic anemia: a review.
Miano M; Dufour C
Int J Hematol; 2015 Jun; 101(6):527-35. PubMed ID: 25837779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
